| Nov 6 |
Amicus Therapeutics: Q3 Earnings Snapshot
|
| Nov 6 |
Amicus Therapeutics Non-GAAP EPS of $0.10 beats by $0.05, revenue of $141.52M beats by $6.56M
|
| Nov 6 |
Amicus Therapeutics Announces Third Quarter 2024 Financial Results and Corporate Updates
|
| Nov 5 |
Amicus Therapeutics Q3 2024 Earnings Preview
|
| Nov 4 |
Wall Street Analysts Predict a 51.09% Upside in Amicus Therapeutics (FOLD): Here's What You Should Know
|
| Nov 1 |
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2024
|
| Oct 31 |
Will Mirum Pharmaceuticals, Inc. (MIRM) Report Negative Q3 Earnings? What You Should Know
|
| Oct 30 |
Amicus Therapeutics (FOLD) Reports Next Week: Wall Street Expects Earnings Growth
|
| Oct 28 |
Amicus Therapeutics to Announce Third Quarter 2024 Financial Results on November 6, 2024
|
| Oct 25 |
GitLab and Baidu have been highlighted as Zacks Bull and Bear of the Day
|
